Worldwide trends in scientific publications on association of gut microbiota with obesity

Document Type: Review Article

Authors

1 Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

2 Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

3 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

4 Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran

5 Department of Microbiology and Immunology, Rega Institute, KU Leuven, Leuven, Belgium

Abstract

Objective(s): Recent evidence has shown underlying roles of gut dysbiosis and metabolic endotoxemia in obesity and its complications. Despite the large number of experimental and clinical researches performed on gut microbiota and obesity, no bibliometrics’ study has been conducted so far. We aimed to assess the trend of global scientific publications in the field of gut microbiota and obesity.
Materials and Methods: The bibliometrics’ data from January 2000 to April 2017 were retrieved based on Scopus database. The analysis of the publication year, main source, citation, subject area, co-authorship network, and geographical distribution were carried out, accordingly. The data were analyzed using the Scopus analysis tools, SPSS version 15 and Visualizing Scientific Landscapes (VOS) viewer version 1.6.5.
Results: Out of 4384 documents that were identified, the United States published the highest number (28.2%), followed by China and United Kingdom. The number of publications showed an increasing trend over the years of which the most productive year was 2016. The leading subject area was medicine. Most of published scientific documents were original articles and the top source was “PLoS One”. The documents were cited totally 153576 times with average citations per article as 35.03, and h-index of 159. Top author in the co-authorship network assessment was “Wang J.” from China.
Conclusion: This study could provide practical sources to researchers to find highly cited studies. Moreover, the study could pave the way for researchers to be engaged in studies which potentially lead to more publication in the field.

Keywords

Main Subjects


1. Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord 2014;13:121.
2. Tabatabaei-Malazy O, Khodaeian M, M.Amoli M. Association between genetic variants and obesity in Iranian population: review article. Iran J Public Health 2014;43:71-82.
3. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am 2010;39:1-7.
4. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J 2014;26:20-24.
5. Palou A, Bonet ML. Challenges in obesity research. Nutr Hosp 2013;28 Suppl 5:144-153.
6. Ejtahed HS, Soroush AR, Angoorani P, Larijani B, Hasani-Ranjbar S. Gut Microbiota as a target in the pathogenesis of metabolic disorders: a new approach to novel therapeutic agents. Horm Metab Res 2016;48:349-358.
7. Homayouni-Rad A, Soroush AR, Khalili L, Norouzi-Panahi L, Kasaie Z, Ejtahed HS. Diabetes Management by Probiotics: Current knowledge and future pespective. Int J Vitam Nutr Res 2017:1-13.
8. Kvit KB, Kharchenko NV. Gut microbiota changes as a risk factor for obesity. Wiad Lek 2017;70:231-235.
9. Dore J, Multon MC, Behier JM. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect? Therapie 2017;72:21-38.
10. Dahiya DK, Renuka, Puniya M, Shandilya UK, Dhewa T, Kumar N, et al. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: A review. Front Microbiol 2017;8:563.
11. Tabatabaei-Malazy O, Atlasi R, Larijani B, Abdollahi M. Trends in publication on evidence-based antioxidative herbal medicines in management of diabetic nephropathy. J Diabetes Metab Disord 2015;15:1-8.
12. Tabatabaei-Malazy O, Ramezani A, Atlasi R, Larijani B, Abdollahi M. Scientometric study of academic publications on antioxidative herbal medicines in type 2 diabetes mellitus. J Diabetes Metab Disord 2016;15:48.
13. Bar-Ilan J. Citations to the “Introduction to informetrics” indexed by WOS, Scopus and Google Scholar. Scientometrics 2010;82:495-506.
14. Garfield E. The history and meaning of the journal impact factor. JAMA 2006;295:90-93.
15. Saha S, Saint S, Christakis DA. Impact factor: a valid measure of journal quality? J Med Libr Assoc 2003;91:42-46.
16. Baldock C, Ma R, Orton CG. Point/counterpoint. The h index is the best measure of a scientist’s research productivity. Med Phys 2009;36:1043-1045.
17. Van Eck NJ, Waltman L. Text mining and visualization using VOSviewer. Int Soc Scientometr Informetr Newslett 2011;7:50-54.
18. Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE. Comparison of SCImago journal rank indicator with journal impact factor. FASEB J 2008;22:2623-2628.
19. Philippe Mongeon, Ade`le Paul-Hus. The journal coverage of Web of Science and Scopus: a comparative analysis. Scientometrics 2016;106:213-228.
20. Kulkarni AV, Aziz B, Shams I, Busse JW. Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals. JAMA 2009;302:1092-1096.
21. Proctor LM. The human microbiome project in 2011 and beyond. Cell Host Microbe 2011;10:287-291.
22. Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012;486:215-221.
23. Robles-Alonso V, Guarner F. From basic to applied research: lessons from the human microbiome projects. J Clin Gastroenterol 2014;48 Suppl 1:S3-4.
24. Blanco-Miguez A, Gutierrez-Jacome A, Fdez-Riverola F, Lourenco A, Sanchez B. MAHMI database: a comprehensive MetaHit-based resource for the study of the mechanism of action of the human microbiota. Database 2017;2017.
25. Dusko Ehrlich S. [Metagenomics of the intestinal microbiota: potential applications]. Gastroenterol Clin Biol 2010;34 Suppl 1:S23-S28.
26. Finotello F, Mastrorilli E, Di Camillo B. Measuring the diversity of the human microbiota with targeted next-generation sequencing. Brief Bioinform 2018;19:679-692.
27. Ji B, Nielsen J. From next-generation sequencing to systematic modeling of the gut microbiome. Front Genet 2015;6:219-227.
28. Rogers GB, Bruce KD. Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application. Mol Diagn Ther 2010;14:343-350.
29. Ejtahed HS, Hasani-Ranjbar S, Larijani B. Human Microbiome as an approach to personalized medicine. Altern Ther Health Med 2017; 23:8-9.
30. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031.
31. Newman ME. The structure of scientific collaboration networks. Proc Natl Acad Sci U S A 2001;98:404-409.